Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-06-21

Clinical Trial Update: A Study to Evaluate Avastin in Combination With Standard Chemotherapy to Treat Colorectal Cancer [Phase 3]

View source ↗

Summary

This report summarizes a Phase 3 trial evaluating bevacizumab (Avastin) in combination with standard chemotherapy for colorectal cancer. The study has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avastin (bevacizumab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Colorectal Cancer | Phase 3 | Status: COMPLETED